No Data
US Stock MarketDetailed Quotes
ERNA Eterna Therapeutics
Watchlist
0.900
-0.015-1.65% Trading 11/30 12:51 ET
0.900High0.860Low22.64KVolume
0.900Open0.915Pre Close19.96KTurnover0.65%Turnover RatioLossP/E (TTM)4.87MMarket Cap6.33052wk HighLossP/E (Static)5.41MShares0.86052wk Low1.37P/B3.14MFloat Cap1613.400Historical High--Dividend TTM3.49MShs Float0.860Historical Low--Div YieldTTM4.39%Amplitude0.881Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Eterna Therapeutics Company
Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.
News
Eterna Therapeutics Appoints Dr. James Bristol to Board of Directors
Calidi Biotherapeutics Names Andrew Jackson as Chief Financial Officer
Calidi Biotherapeutics (CLDI) said Monday that Andrew Jackson was appointed chief financial officer. Jackson, 54, most recently served as CFO of Eterna Therapeutics (ERNA), Calidi Biotherapeutics said
Eterna Therapeutics Teams With Lineage Cell on Transplant Therapies
Comments
The appointment of Dr. Bristol for Eterna Therapeutics is positive due to his vast experience in drug discovery. His track record could drive the company's strategic direction.
Press Release: Eterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors
$Eterna Therapeutics(ERNA.US$ Bid and Ask gap price too far must Delete 👺👊👹
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--